Stock SOLIGENIX INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Soligenix Inc OTC Bulletin Board

Equities

US8342232084

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Soligenix Inc
Jun. 25 Soligenix, Inc. Announces Positive Clinical Results from A Comparative Study Evaluating Hybryte?? Against Valchlor®? in the Treatment of Cutaneous T-Cell Lymphoma CI
May. 23 Sector Update: Health Care Stocks Retreat Late Afternoon MT

Chart calendar Soligenix Inc

bcaa2492273bab.jZXgeRVvGdmpsiDK5wBBVLo2SV5AbOdmn18KPxm3nhw.-O3VTUQ6QLbA10-igjR3JfBZfwkuLpBW-C95dnb7xyT98ZIURF5AkJuEeQ~2348af0833c01168bc6765a81173b9e1

Upcoming events on Soligenix Inc

2024-08-14 Q2 2024 Earnings Release (Projected)
2024-11-12 Q3 2024 Earnings Release (Projected)
2025-03-31 Q4 2024 Earnings Release (Projected)

Past events on Soligenix Inc

2024-06-17 08:45 am American Society of Microbiology Microbe Conference - Axel Lehrer
2024-06-17 08:15 am American Society of Microbiology Microbe Conference - Panel
2024-06-05 Reverse Split: 1 of 16
2024-05-30 09:00 am Annual General Meeting - Second Call
2024-05-23 09:00 am Annual General Meeting - First Call
2024-05-22 10:15 pm Vaccine Technology Conference
2024-05-20 Alliance Global Partners Healthcare Showcase
2024-05-12 BioPartnering Conference
2024-05-10 07:30 am Q1 2024 Earnings Release
2024-05-06 Aegis Virtual Conference
2024-05-06 Aegis Virtual Conference
2024-03-15 07:30 am Q4 2023 Earnings Release
2024-02-20 RedChip Investor Group Call
2024-01-29 Microcap Conference
2024-01-25 09:30 am Sequire Investor Summit
2023-12-15 09:00 am Annual General Meeting
2023-11-13 07:30 am Q3 2023 Earnings Release
2023-10-18 ThinkEquity Conference
2023-08-21 07:30 am Q2 2023 Earnings Release
2023-05-15 07:30 am Q1 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		4,60
3,79
21.44%		2,40
2,20
9.25%		0,80
0,72
10.42%		0,90
0,79
13.71%		0,84
0,80
5.25%
0,71

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-10,5
-10,0
-4.9%		-13,6
-14,1
3.69%		-13,1
-12,2
-7.64%		-14,2
-13,9
-2.68%		-7,70
-7,44
-3.47%
-8,32

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,97
-9,90
-0.65%		-18,5
-15,4
-19.95%		-13,4
-12,4
-8.19%		-15,0
-14,9
-0.36%		-7,91
-7,50
-5.45%
-8,40

Net income
Million USD		Released
Forecast
Spread 		-9,40
-9,29
-1.19%		-17,7
-14,4
-22.86%		-12,6
-12,2
-2.95%		-13,8
-14,0
1.13%		-6,14
-6,35
3.28%
-8,58

EPS
USD		Released
Forecast
Spread 		-115
-118
2.04%		-154
-128
-19.63%		-74,4
-73,2
-1.64%		-77,0
-76,8
-0.21%		-12,6
-13,2
4.24%
-8,20

Announcement Date30/03/2030/03/2129/03/2231/03/2315/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		0,20
0,10
100%		0,40
0,20
100%		0,17
0,20
-16.93%		0,32
0,20
58.58%		0,30
0,20
50%		0,20
0,20
0%		0,13
0,20
-34.78%		0,24
0,20
22.41%		0,10
0,20
-50%
0,20


0,20


0,20







EBIT
Million USD		Released
Forecast
Spread 		-4,20
-2,70
-55.65%		-3,40
-3,56
4.59%		-3,08
-3,42
10.01%		-3,57
-3,18
-12.35%		-2,15
-3,50
38.55%		-1,63
-3,01
45.77%		-1,78
-2,89
38.4%		-2,14
-1,86
-14.97%		-2,12
-2,10
-0.81%
-2,01


-2,11


-2,11







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-4,35
-2,80
-55.32%		-3,54
-3,10
-14.25%		-3,31
-3,30
-0.27%		-3,75
-3,70
-1.45%		-2,21
-3,60
38.69%		-1,61
-3,90
58.67%		-1,66
-4,30
61.33%		-2,43
-2,00
-21.33%		-1,92
-2,10
8.79%
-2,10


-2,20


-2,20







Net income
Million USD		Released
Forecast
Spread 		-4,30
-2,80
-53.57%		-2,40
-3,72
35.41%		-3,31
-3,58
7.61%		-3,76
-3,34
-12.6%		-1,00
-3,60
72.22%		-1,60
-3,16
49.43%		-1,66
-3,10
46.29%		-1,82
-2,02
9.77%		-1,90
-2,10
9.52%
-2,11


-2,21


-2,21







EPS
USD		Released
Forecast
Spread 		-24,0
-16,8
-42.86%		-14,4
-20,4
29.41%		-19,2
-21,6
11.11%		-19,8
-18,0
-10.22%		-5,76
-20,0
71.2%		-3,52
-6,08
42.11%		-2,56
-4,64
44.83%		-2,56
-3,12
17.95%		-2,88
-3,04
5.26%
-1,78


-1,91


-1,89


-1,76


-1,76

Announcement Date13/05/2212/08/2210/11/2231/03/2315/05/2321/08/2313/11/2315/03/2410/05/24-----

Upcoming sector events for Soligenix Inc

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Soligenix Inc

2024-06-05 03:51 am PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
2024-05-17 07:00 am AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
2024-05-15 08:05 am THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-14 04:05 pm ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 04:00 pm ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. SNGX Stock
  4. Stock
  5. Calendar Soligenix Inc